Clinical Performance of the Afirma Gene Sequencing Classifier: Real World Experience and the Optimization of Thyroid Nodule Management Sponsored by Veracyte
Saturday, May 14, 2022
12:30 PM – 1:30 PM
Location: Learning Lab B - AACE Learning Zone
Presenter(s)
Joshua Klopper, MD
Medical Director, Endocrinology Veracyte, Inc. Denver, Colorado, United States
Disclosure: Disclosure information not submitted.
During this presentation, we will: 1. Review the independent, post-validation performance studies of the Afirma GSC relative to the clinical validation study 2. Compare the value of the Afirma GSC to the GEC and other molecular marker tests in hurthle cell lesions 3. Highlight the value of Afirma Xpression Atlas to personalize thyroid nodule and thyroid cancer management
Participants should be aware of the following financial/non-financial relationships:
Joshua Klopper, MD: Disclosure information not submitted.